Exhibit 1.1


                              CENDANT CORPORATION
                           (a Delaware corporation)



                         6.250% Senior Notes due 2008
                         7.375% Senior Notes due 2013

                            UNDERWRITING AGREEMENT



                                January 8, 2003


<page>




                        CENDANT CORPORATION
                     (a Delaware corporation)

                   6.250% senior Notes due 2008
                   7.375% Senior Notes due 2013


                      UNDERWRITING AGREEMENT

                                               January 8, 2003


To the Underwriters named in Schedule I

Ladies and Gentlemen:

      Cendant Corporation, a Delaware corporation (the "Company"), proposes to
issue and sell to the underwriters named in Schedule I (the "Underwriters")
the principal amount of certain of its debt securities specified in Schedule
II (the "Securities") on the terms and conditions stated herein and in
Schedule II. The Securities will be issued pursuant to an indenture to be
dated as of January 13, 2003 (the "Indenture") between the Company and The
Bank of Nova Scotia Trust Company of New York, as trustee (the "Trustee").

      The Company has filed with the Securities and Exchange Commission (the
"Commission") a registration statement on Form S-3 (Registration No.
333-65858), including a prospectus, relating to certain of its debt securities
(including the Securities), preferred stock, CD common stock, stock purchase
contracts, stock purchase units and warrants and the offering thereof from
time to time in accordance with Rule 415 under the Securities Act of 1933, as
amended (the "1933 Act"). Such registration statement was declared effective
by the Commission on August 16, 2001. As provided in Section 3(a), a
prospectus supplement reflecting the terms of the Securities, the terms of the
offering thereof and the other matters set forth therein will be filed
pursuant to Rule 424 under the 1933 Act. Such prospectus supplement, in the
form first filed after the date hereof pursuant to Rule 424, is herein
referred to as the "Prospectus Supplement". Such registration statement, as
amended at the date hereof, together with any registration statements filed by
the Company pursuant to Rule 462(b) under the 1933 Act, including the exhibits
thereto and the documents incorporated by reference therein, is herein called
the "Registration Statement", and the base prospectus included therein
relating to all offerings of debt securities, preferred stock, CD common
stock, stock purchase contracts, stock purchase units and warrants under the
Registration Statement, as supplemented by the Prospectus Supplement, is
herein called the "Prospectus", except that, if such base prospectus is
amended or supplemented on or prior to the date on which the Prospectus
Supplement is first filed pursuant to Rule 424, the term "Prospectus" shall
refer to the base prospectus, as so amended or supplemented and as
supplemented by the Prospectus Supplement, in either case including the
documents filed by the Company with the Commission pursuant to the Securities
Exchange Act of 1934, as amended (the "1934 Act"), that are incorporated by
reference therein.

      You have advised us that you and the other Underwriters, acting
severally and not jointly, desire to purchase the Securities and that you have
been authorized by the other Underwriters to execute this Underwriting
Agreement (the "Agreement") on their behalf.

Section 1. Representations and Warranties.

        (a)   The Company represents and warrants to and agrees with each
              Underwriter that:

              (i) On the original effective date of the Registration
        Statement, on the effective date of the most recent post-effective
        amendment thereto, if any, and on the date of the filing by the
        Company of any annual report on Form 10-K after the original filing of
        the Registration Statement, the Registration Statement complied in all
        material respects with the requirements of the 1933 Act and the rules
        and regulations of the Commission there under (the "1933 Act
        Regulations"), the Trust Indenture Act of 1939, as amended (the "1939
        Act"), and the rules and regulations of the Commission under the 1939
        Act (the "1939 Act Regulations") and did not contain an untrue
        statement of a material fact or omit to state a material fact required
        to be stated therein or necessary to make the statements therein not
        misleading; on the date hereof and at the Closing Time (as defined
        below), the Registration Statement, and any amendments thereof, and
        the Prospectus, and any amendments thereof and supplements thereto,
        comply and will comply in all material respects with the requirements
        of the 1933 Act, the 1933 Act Regulations, the 1939 Act and the 1939
        Act Regulations, and neither the Registration Statement nor any
        amendments thereof include or will include an untrue statement of a
        material fact or omit or will omit to state any material fact required
        to be stated therein or necessary to make the statements therein not
        misleading, and neither the Prospectus, nor any amendments thereof and
        supplements thereto, include or will include an untrue statement of a
        material fact or omit or will omit to state any material fact required
        to be stated therein or necessary to make the statements therein, in
        light of the circumstances under which they were made, not misleading;
        provided, however, that the Company makes no representations or
        warranties as to statements or omissions from the Registration
        Statement or Prospectus made in reliance upon and in conformity with
        information furnished in writing to the Company by or on behalf of any
        Underwriter expressly for use in the Registration Statement or the
        Prospectus.

              (ii) The documents incorporated by reference in the Prospectus,
        at the time they were filed with the Commission, complied in all
        material respects with the requirements of the 1934, and the rules and
        regulations of the Commission thereunder (the "1934 Act Regulations")
        and, when read together with the other information in the Prospectus,
        do not and will not, on the date hereof and at the Closing Time,
        include an untrue statement of a material fact or omit to state a
        material fact required to be stated therein or necessary to make the
        statements therein, in light of the circumstances under which they
        were made, not misleading.

              (iii) The accountants (individually an "Accountant" and together
        the "Accountants"), who have reported upon the audited financial
        statements and schedules included or incorporated by reference in the
        Registration Statement, are each independent public accountants as
        required by the 1933 Act and the 1933 Act Regulations with respect to
        (i) the Company and (ii) each corporation whose financial statements
        have been included in the Registration Statement for each of the years
        reported on by the Accountants.

              (iv) This Agreement has been duly authorized, executed and
        delivered by the Company.

              (v) The consolidated financial statements included or
        incorporated by reference in the Registration Statement and the
        Prospectus, together with the related schedules and notes, present
        fairly the consolidated financial position of the Company and its
        consolidated subsidiaries as at the dates indicated and the results of
        their operations for the periods specified. Except as otherwise stated
        therein, such financial statements have been prepared in conformity
        with generally accepted accounting principles ("GAAP") applied on a
        consistent basis throughout the periods involved. The financial
        statement schedules, if any, included or incorporated by reference in
        the Registration Statement present fairly in accordance with GAAP the
        information required to be stated therein. The selected financial data
        included in the Prospectus present fairly the information shown
        therein and have been compiled on a basis consistent with that of the
        audited financial statements incorporated by reference in the
        Registration Statement. The pro forma financial statements and related
        notes thereto included or incorporated by reference in the Prospectus
        present fairly the information shown therein, have been prepared in
        accordance with the Commission's rules and guidelines with respect to
        pro forma financial statements and have been properly compiled on the
        pro forma bases described therein, and the assumptions used in the
        preparation thereof are reasonable and the adjustments used therein
        are appropriate to give effect to the transactions or circumstances
        referred to therein.

              (vi) The Company is duly organized and is validly existing in
        good standing as a corporation under the laws of the State of
        Delaware, with corporate power and corporate authority to own, lease
        and operate its properties and conduct its business as presently
        conducted and as described in the Prospectus. The Company is qualified
        as a foreign corporation to transact business and is in good standing
        in each other jurisdiction in which it owns or leases property of a
        nature, or transacts business of a type, that would make such
        qualification necessary, except to the extent that the failure to so
        qualify or be in good standing would not have a material adverse
        change in the condition, financial or otherwise, or in the earnings,
        business affairs or business prospects of the Company and its
        consolidated subsidiaries considered as one enterprise, whether or not
        arising in the ordinary course of business (a "Material Adverse
        Effect").

              (vii) Each significant subsidiary (as such term is defined in
        clauses (1) and (2) of Rule 1-02(w) of Regulation S-X promulgated
        under the Securities Act), if any, of the Company (each, a
        "Significant Subsidiary") is duly organized and is validly existing
        and in good standing under the laws of the jurisdiction of its
        incorporation with corporate power and corporate authority under such
        laws to own, lease and operate its properties and conduct its
        business. Each Significant Subsidiary is duly qualified to transact
        business as a foreign corporation and is in good standing in each
        other jurisdiction in which it owns or leases property of a nature, or
        transacts business of a type, that would make such qualification
        necessary, except to the extent that the failure to so qualify or be
        in good standing would not have a Material Adverse Effect. Except as
        otherwise stated in the Registration Statement and Prospectus, all of
        the outstanding shares of capital stock of each Significant Subsidiary
        have been duly authorized and validly issued and are fully paid and
        nonassessable and are owned by the Company, directly or through one or
        more Significant Subsidiaries, free and clear of any pledge, lien,
        security interest, charge, claim, equity or encumbrance of any kind
        (each, a "Lien"), except for such Liens as are not, individually or in
        the aggregate, material to the Company and its Significant
        Subsidiaries, considered as one enterprise.

              (viii) The Indenture has been duly authorized and when executed
        and delivered by the Company, will constitute the valid and binding
        obligation of the Company enforceable in accordance with its terms,
        except to the extent that enforcement thereof may be limited by (i)
        applicable bankruptcy, insolvency, reorganization, moratorium,
        fraudulent conveyance or other similar laws now or hereafter in effect
        relating to creditors' rights generally and (ii) general principles of
        equity (regardless of whether enforceability is considered in a
        proceeding at law or in equity), and will conform in all material
        respects to the description thereof in the Prospectus. The Indenture
        as executed will be substantially in the form filed as an exhibit to
        the Registration Statement. At the Closing Time, the Indenture will
        comply in all material respects with the requirements of the 1939 Act
        and the 1939 Act Regulations.

              (ix) The sale and issuance of the Securities have been duly
        authorized by the Company. When executed, authenticated, issued and
        delivered in the manner provided for in the Indenture and sold and
        paid for as provided herein, the Securities will constitute valid and
        binding obligations of the Company entitled to the benefits of the
        Indenture and enforceable against the Company in accordance with their
        terms, except to the extent that enforcement thereof may be limited by
        (i) applicable bankruptcy, insolvency, reorganization, moratorium,
        fraudulent conveyance or similar laws now or hereafter in effect
        relating to creditors' rights generally and (ii) general principles of
        equity (regardless of whether enforceability is considered in a
        proceeding in equity or at law); the Securities will conform in all
        material respects to the description thereof in the Prospectus.

              (x) All of the outstanding shares of capital stock of the
        Company have been authorized and validly issued and are fully paid and
        non-assessable; no holder thereof is or will be subject to personal
        liability by reason of being such a holder.

              (xi) Since the respective dates as of which information is given
        in the Registration Statement and the Prospectus and except as
        otherwise stated therein, (A) there has been no material adverse
        change and no development with respect to the Company that would
        result in a Material Adverse Effect, (B) there have been no
        transactions entered into by the Company or any of its subsidiaries,
        other than those arising in the ordinary course of business, that are
        material with respect to the Company and its subsidiaries, considered
        as one enterprise, and (C) except for regular dividends on the common
        stock in amounts per share that are consistent with past practice or
        the applicable charter document or supplement thereto, respectively,
        there has been no dividend or distribution of any kind declared, paid
        or made by the Company on any class of its capital stock.

              (xii) Neither the Company nor any of its Significant
        Subsidiaries is in violation of its charter or by-laws. None of the
        Company or any of its Significant Subsidiaries is in default in the
        performance or observance of any obligation, agreement, covenant or
        condition contained in any contract, indenture, mortgage, note, lease,
        loan or credit agreement or any other agreement or instrument (the
        "Agreements and Instruments") to which the Company or any of its
        Significant Subsidiaries is a party or by which any of them may be
        bound, or to which any of the property or assets of the Company or any
        Significant Subsidiary is subject, or in violation of any applicable
        law, rule or regulation or any judgment, order or decree of any
        government, governmental instrumentality or court, domestic or
        foreign, having jurisdiction over the Company or any of its
        Significant Subsidiaries or any of their respective properties or
        assets, which violation or default would, singly or in the aggregate,
        have a Material Adverse Effect.

              (xiii) The execution and delivery by the Company of this
        Agreement and the Indenture, the issuance and delivery of the
        Securities, the consummation by the Company of the transactions
        concerning the Securities contemplated herein and in the Registration
        Statement and compliance by the Company with the terms of this
        Agreement and the Indenture, have, in each case, been duly authorized
        by all necessary corporate action on the part of the Company and do
        not and will not result in any violation of the certificate of
        incorporation or by-laws of the Company, and do not and will not
        conflict with, or result in a breach of any of the terms or provisions
        of, or constitute a default under, or result in the creation or
        imposition of any lien, charge or encumbrance upon any property or
        assets of the Company or any subsidiary under (A) any Agreement or
        Instrument to which the Company or any subsidiary is a party or by
        which it may be bound or to which any of its properties may be subject
        (except for such conflicts, breaches or defaults or liens, charges or
        encumbrances that would not have a Material adverse Effect or (B) any
        existing applicable law, rule, regulation (other than state
        securities, foreign securities or Blue Sky laws, rules and
        regulations), judgment, order or decree of any government,
        governmental instrumentality or court, domestic or foreign, having
        jurisdiction over the Company or any subsidiary or any of their
        respective properties (except for such conflicts, breaches or defaults
        or liens, charges or encumbrances that would not have a Material
        Adverse Effect).

              (xiv) Except (i) as may be required under the 1933 Act, the 1939
        Act and the rules and regulations promulgated thereunder and (ii) as
        required by the state or foreign securities or "blue sky" laws, no
        authorization, approval, consent, order, registration or qualification
        of or with any court or governmental authority or agency is required
        for the performance by the Company of its obligations hereunder, in
        connection with the offering, issuance or sale of the Securities
        hereunder or the consummation of the transactions contemplated by this
        Agreement, or for the due execution, delivery or performance of the
        Indenture by the Company, except such as have been obtained and made
        under the federal securities laws.

              (xv) There are no contracts or documents which are required to
        be described in the Registration Statement or the Prospectus which
        have not been so described and filed as required.

              (xvi) Except as otherwise disclosed in the Prospectus, there is
        no action, suit or proceeding before or by any government,
        governmental instrumentality or court, domestic or foreign, now
        pending or, to the knowledge of the Company, threatened against or
        affecting the Company or any of its Significant Subsidiaries that is
        required to be disclosed in the Prospectus or that might reasonably be
        expected to result in a Material Adverse Effect, or that might
        reasonably be expected to materially and adversely affect the
        consummation of the transactions contemplated in this Agreement.

              (xvii) Subject to each of the franchise and license agreements
        entered into by the Company or any of its Significant Subsidiaries,
        the Company and each of the Significant Subsidiaries own or have the
        unrestricted right to use such patents, patent licenses, trademarks,
        trademark licenses, service marks, service mark licenses and trade
        names and registrations thereof (collectively, "Intellectual
        Property") as are necessary to carry on their respective businesses as
        presently conducted, except where the failure to own or possess any of
        the Marks (as defined below), Days Inn Marks (as defined below) or
        Ramada Marks (as defined below) would not have a Material Adverse
        Effect. In addition to, and not in limitation of, anything else
        contained in this paragraph (xvii), the Company or a Significant
        Subsidiary (y) is the exclusive owner of all rights, title and
        interest (subject to all existing franchise and license agreements
        referred to above) in and to the Marks within the United States and
        outside the United States is the owner of the registrations and
        applications as are necessary to carry on its business as such
        description is incorporated by reference in the Prospectus and as
        currently conducted, except where the failure to be such owner would
        not have a Material Adverse Effect and (z) is the exclusive licensee
        (i) in the United States and Canada of the Ramada Marks and (ii) in
        the United States of the Days Inn Marks. The Intellectual Property
        with respect to the Company's ERA Franchise Systems, Inc., Century 21
        Real Estate Corporation, Coldwell Banker Corporation, Cendant Mobility
        Services Corporation, Cendant Mortgage Corporation, NRT Incorporated,
        Trendwest Resorts, Inc., Days Inns Worldwide, Inc. (outside the United
        States), Super 8 Motels, Inc., Villager Franchise Systems, Inc.,
        Knights Franchise Systems, Inc., Howard Johnson International, Inc.,
        Travelodge Hotels, Inc., Wingate Inns International, Inc., AmeriHost
        Franchise System, Inc., Fairfield Resorts, Inc., Resort Condominiums
        International, LLC, Avis Rent-A-Car System, Inc. Wright Express LLC,
        PHH Vehicle Management Services Inc., Budget Rent-A-Car System, Inc.,
        Galileo International, Inc., Cheap Tickets, Inc., WizCom
        International, Ltd. and Jackson Hewitts, Inc. businesses (as such
        description is incorporated by reference in the Prospectus and as
        currently conducted) is referred to herein as the "Marks" and the
        Intellectual Property with respect to the Company's Ramada Franchise
        Systems, Inc. and Days Inns Worldwide, Inc. (in the United States)
        businesses (as such descriptions are incorporated by reference in the
        Registration Statement and Prospectus and as currently conducted) are
        referred to herein as the "Ramada Marks" and the "Days Inn Marks",
        respectively.

              (xviii) To the best knowledge of the Company without having made
        any inquiry or independent investigation, no labor problem exists with
        the employees of any party that licenses a franchise, directly or
        indirectly, from a Significant Subsidiary (a "Franchisee") or is
        imminent that could reasonably be expected to have a Material Adverse
        Effect.

              (xix) To the best knowledge of the Company, no dispute exists or
        is imminent with any Franchisee that could reasonably be expected to
        have a Material Adverse Effect.

              (xx) Each Franchisee is such by virtue of being a party to a
        franchise contract with either the Company or a Significant Subsidiary
        and assuming each such contract has been duly authorized, executed and
        delivered by the parties thereto, other than the Company or a
        Significant Subsidiary, each such contract constitutes a valid, legal
        and binding obligation of each party thereto, enforceable against the
        Company or a Significant Subsidiary in accordance with its terms,
        except (A) for any one or more of such franchise contracts as would
        not have a Material Adverse Effect, and (B) to the extent that
        enforcement thereof may be limited by applicable bankruptcy,
        insolvency (including, without limitation, all laws relating to
        fraudulent transfers), reorganization, moratorium or similar laws
        affecting enforcement of creditors' rights generally and except as
        enforcement thereof is subject to general principles of equity
        (regardless of whether enforcement is considered in a proceeding in
        equity or at law).

              (xxi) The Company and each Significant Subsidiary have complied
        and are currently complying in all material respects with the rules
        and regulations of the United States Federal Trade Commission and the
        comparable laws, rules and regulations of each state or state agency
        applicable to the franchising business of the Company and such
        Significant Subsidiary in each state in which the Company or such
        Significant Subsidiary is doing business. The Company and each
        Significant Subsidiary have complied and are currently complying in
        all material respects with the Federal Real Estate Settlement
        Procedures Act and the real estate brokerage laws, rules and
        regulations of each state or state agency applicable to the real
        estate franchising business of the Company and such Significant
        Subsidiary in each state in which the Company or such Significant
        Subsidiary is doing business.

              (xxii) Neither the Company nor any of its Significant
        Subsidiaries has taken or will take, directly or indirectly, any
        action designed to, or that might be reasonably expected to, cause or
        result in stabilization or manipulation of the price of the
        Securities.

              (xxiii) The Company is not an "investment company" or an entity
        "controlled" by an "investment company" as such terms are defined in
        the Investment Company Act of 1940, as amended.

        (b) Any certificate signed by any officer of the Company or any
subsidiary and delivered to you or to counsel for the Underwriters shall be
deemed a representation and warranty by the Company or by a Subsidiary, as
applicable, to each Underwriter as to the matters covered thereby.

Section 2. Purchase and Sale. (a) On the basis of the representations and
warranties herein contained (except as may be otherwise specified in Schedule
II) and subject to the terms and conditions herein set forth, the Company
agrees to sell to each Underwriter, and each Underwriter agrees, severally and
not jointly, to purchase from the Company, at the purchase price to the
Underwriters set forth in Schedule II, the principal amount of Securities set
forth opposite the name of such Underwriter in Schedule I.

        (b) Payment of the purchase price for, and delivery of, the Securities
shall be made at the date, time and location specified in Schedule II, or at
such other date, time or location as shall be agreed upon by the Company and
the Underwriters, or as shall otherwise be provided in Section 11 (such date
and time of payment and delivery being herein called the "Closing Time").
Unless otherwise specified in Schedule II, payment shall be made to the
Company by you by wire or bank transfer of same day funds payable to the
account of the Company, against delivery to you for the respective accounts of
the several Underwriters of the Securities. Such Securities shall be in such
authorized denominations and registered in such names as you may request in
writing at least two full business days before the Closing Time. Such
Securities, which may be in temporary form, will be made available in New York
City for examination and packaging by you not later than 10:00 A.M. on the
business day prior to the Closing Time.

        (c) It is understood that each Underwriter has authorized you, for its
account, to accept delivery of, receipt for, and make payment of the purchase
price for, the Securities that it has agreed to purchase. You, individually
and not as Representatives, may (but shall not be obligated to) make payment
of the purchase price for the Securities to be purchased by any Underwriter
whose payments shall not have been received by the Closing Time.

Section 3. Certain Covenants of the Company. The Company covenants with each
Underwriter as follows:

        (a) Immediately following the execution of this Agreement, the Company
will prepare a Prospectus Supplement that complies with the 1933 Act and the
1933 Act Regulations and that sets forth the principal amount of the
Securities and their terms not otherwise specified in the Indenture, the name
of each Underwriter participating in the offering and the principal amount of
the Securities that each severally has agreed to purchase, the name of each
Underwriter, if any, acting as representative of the Underwriters in
connection with the offering, the price at which the Securities are to be
purchased by the Underwriters from the Company, any initial public offering
price, any selling concession and reallowance any delayed delivery
arrangements and such other information as you and the Company deem
appropriate in connection with the offering of the Securities. The Company
will promptly transmit copies of the Prospectus Supplement to the Commission
for filing pursuant to Rule 424 under the 1933 Act and will furnish to the
Underwriters as many copies of the Prospectus as you shall reasonably request.

        (b) If at any time when the Prospectus is required by the 1933 Act to
be delivered in connection with sales of the Securities any event shall occur
or condition exist as a result of which it is necessary, in the opinion of
counsel for the Underwriters or counsel for the Company, to amend the
Registration Statement or amend or supplement the Prospectus in order that the
Prospectus will not include an untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein not
misleading in the light of the circumstances existing at the time it is
delivered to a purchaser, or if it shall be necessary, in the opinion of
either such counsel, at any such time to amend the Registration Statement or
amend or supplement the Prospectus in order to comply with the requirements of
the 1933 Act or the 1933 Act Regulations, the Company will promptly prepare
and file with the Commission, subject to Section 3(f), such amendment or
supplement as may be necessary to correct such untrue statement or omission or
to make the Registration Statement or the Prospectus comply with such
requirements.

        (c) During the period when the Prospectus is required by the 1933 Act
to be delivered in connection with sales of the Securities, the Company will,
subject to Section 3(f), file all documents required to be filed with the
Commission pursuant to Section 13, Section 14 or Section 15(d) of the 1934 Act
within the time periods required by the 1934 Act and the 1934 Act Regulations.

        (d) During the period when the Prospectus is required by the 1933 Act
to be delivered in connection with sales of the Securities, the Company will
inform you of its intention to file any amendment to the Registration
Statement or any supplement or revision to the Prospectus, whether pursuant to
the 1933 Act, the 1934 Act or otherwise; and the Company will furnish you with
copies of any such amendment or supplement at a reasonable time in advance of
filing; and will not file any such documents to which the Underwriters or
their counsel shall reasonably object.

        (e) During the period when the Prospectus is required by the 1933 Act
to be delivered in connection with sales of the Securities, the Company will
notify you immediately, and confirm the notice in writing, (i) of the
effectiveness of any post-effective amendment to the Registration Statement,
(ii) of the filing of any supplement to the Prospectus, (iii) of the receipt
of any comments from the Commission with respect to the Registration
Statement, the Prospectus or the Prospectus Supplement, (iv) of any request by
the Commission for any amendment to the Registration Statement or any
supplement to the Prospectus or for additional information relating thereto or
to any document incorporated by reference in the Prospectus and (v) of the
issuance by the Commission of any stop order suspending the effectiveness of
the Registration Statement, of the suspension of the qualification of the
Securities for offering or sale in any jurisdiction, or of the institution or
threatening of any proceeding for any of such purposes. The Company will use
every reasonable effort to prevent the issuance of any such stop order or of
any order suspending such qualification and, if any such order is issued, to
promptly obtain the lifting thereof.

        (f) The Company has furnished or will, upon request, furnish to you,
without charge, one signed copy of the Registration Statement (as originally
filed), of any Rule 462(b) Registration Statement, and of all amendments
thereto, whether filed before or after the Registration Statement became
effective (including exhibits filed therewith or incorporated by reference
therein and documents incorporated or deemed to be incorporated by reference
therein) (through the end of the period when the Prospectus is required by the
1933 Act to be delivered in connection with sales of the Securities) and
conformed copies of all consents and certificates of experts, as you may
reasonably request.

        (g) The Company will use its best efforts, in cooperation with the
Underwriters, to qualify the Securities for offering and sale under the
applicable securities laws of such states and other jurisdictions as you may
designate; provided, however, that the Company shall not be obligated to file
any general consent to service of process or to qualify as a foreign
corporation or as a dealer in securities in any jurisdiction in which it is
not so qualified or to subject itself to taxation in respect of doing business
in any jurisdiction in which it is not otherwise so subject. The Company will
file such statements and reports as may be required by the laws of each
jurisdiction in which the Securities have been qualified as above provided.

        (h) The Company will make generally available to its security holders
as soon as practicable, but not later than 45 days (or 90 days, in the case of
a period that is also the Company's fiscal year) after the close of the period
covered thereby, an earnings statement of the Company (in form complying with
the provisions of Rule 158 of the 1933 Act Regulations), covering a
twelve-month period beginning not later than the first day of the Company's
fiscal quarter next following the "effective date" (as defined in said Rule
158) of the Registration Statement.

        (i) During the period beginning on the date hereof and continuing to
and including the Closing Time, the Company will not, directly or indirectly,
offer for sale, sell, pledge or otherwise dispose of (or enter into any
transaction or device which is designed to, or could be expected to, result in
the disposition by any person at any time in the future of) any debt
securities of or guaranteed by the Company which are substantially similar to
the Securities without the prior consent of the Underwriters.

Section 4. Payment of Expenses. The Company will pay and bear all costs and
expenses incident to the performance of its obligations under this Agreement,
including, without limitation, (a) the preparation, printing and filing of the
Registration Statement (including financial statements and exhibits), as
originally filed and as amended, any preliminary prospectus supplements and
the Prospectus and any amendments or supplements thereto, and the cost of
furnishing copies thereof to the Underwriters, (b) the printing and
distribution of this Agreement, any agreement among Underwriters, the
Indenture, and such other documents as may be required in connection with the
offering purchase, sale and delivery of the Securities, (c) the preparation,
issuance and delivery of the certificates for the Securities to the
Underwriters, (d) the fees and disbursements of the Company's counsel and
accountants, (e) the qualification of the Securities under the applicable
securities laws, (f) any fees charged by rating agencies for rating the
Securities, (g) the reasonable fees and disbursements of counsel in connection
with the Blue Sky survey and (h) the fees and expenses of the Trustee,
including the fees and disbursements of counsel for the Trustee, in connection
with the Indenture and the Securities.

        If this Agreement is terminated by you in accordance with the
provisions of Section 5 or Section 10(a)(i), the Company shall reimburse the
Underwriters for all of their reasonable out-of-pocket expenses, including the
reasonable fees and disbursements of counsel for the Underwriters, incurred by
them in connection with the public offering of the Securities.

Section 5. Conditions of the Underwriters' Obligations. Except as otherwise
provided in Schedule II hereto, the obligations of the several Underwriters to
purchase and pay for the Securities that they have respectively agreed to
purchase hereunder are subject to (i) the accuracy of the representations and
warranties of the Company contained herein or in certificates of the Company's
officers delivered pursuant to the provisions hereof, (ii) the performance by
the Company of its obligations hereunder, (iii) the delivery to the
Underwriters at the Closing Time by the Company of all of the Securities and
(iv) the following further conditions:

        (a) The Registration Statement has become effective, including any
Rule 462(b) Registration Statement, and at the Closing Time, no stop order
suspending the effectiveness of the Registration Statement shall have been
issued under the 1933 Act and no proceedings for that purpose shall have been
instituted or shall be pending or, to your knowledge or the knowledge of the
Company, shall be contemplated by the Commission, and any request on the part
of the Commission for additional information shall have been complied with to
the reasonable satisfaction of counsel for the Underwriters.

        (b) At the Closing Time, you shall have received a signed opinion of
Eric J. Bock, Executive Vice President, Law and Corporate Secretary of the
Company, and a signed opinion of Skadden, Arps, Slate, Meagher & Flom LLP,
special counsel for the Company, each dated as of the Closing Time, in form
and substance reasonably satisfactory to counsel for the Underwriters as set
forth on Exhibits A and B attached hereto.

        Such counsel may also state that, insofar as such opinion involves
factual matters, they have relied, to the extent they deem proper, upon
certificates of officers of the Company, as the case may be, and certificates
of public officials; provided that such certificates have been delivered to
the Underwriters.

        In giving the opinions referred to in above, such counsel may rely, as
to all matters governed by the laws of jurisdictions other than those in which
they are expert, upon opinions of other counsel who shall be counsel
reasonably satisfactory to counsel for the Underwriters, in which case the
opinion shall state that they believe you and they are justified and entitled
to so rely.

        (c) At the Closing Time, you shall have received the favorable opinion
of Shearman & Sterling, counsel for the Underwriters, dated as of the Closing
Time.

        (d) At the Closing Time, (i) the Registration Statement and the
Prospectus, as they may then be amended or supplemented, shall contain all
statements that are required to be stated therein under the 1933 Act and the
1933 Act Regulations and in all material respects shall conform to the
requirements of the 1933 Act and the 1933 Act Regulations and the 1939 Act and
the 1939 Act Regulations, the Company shall have complied in all material
respects with Rule 430A (if it shall have elected to rely thereon) and (A) the
Registration Statement, as it may then be amended or supplemented, shall not
contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein
not misleading and (B) the Prospectus, as it may be amended or supplemented,
will not include an untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading, (ii) there
shall not have been, since the respective dates as of which information is
given in the Registration Statement, any material adverse change in the
condition, financial or otherwise, earnings, business affairs or business
prospects of the Company and its Significant Subsidiaries, considered as one
enterprise, whether or not arising in the ordinary course of business,
financial or otherwise, (iii) no action, suit or proceeding shall be pending
or, to the knowledge of the Company, threatened against the Company or any
Significant Subsidiary that would be required to be set forth in the
Prospectus other than as set forth therein and no proceedings shall be pending
or, to the knowledge of the Company, threatened against the Company or any
Significant Subsidiary before or by any federal, state or other commission,
board or administrative agency wherein an unfavorable decision, ruling or
finding would materially adversely affect the financial condition, earnings,
business affairs or business prospects of the Company and its Significant
Subsidiaries, considered as one enterprise, other than as set forth in the
Prospectus, (iv) the Company shall have complied in all material respects with
all agreements and satisfied in all material respects all conditions included
herein on its part to be performed and satisfied at or prior to the Closing
Time and (v) the other representations and warranties of the Company set forth
in Section 1(a) shall be accurate as though expressly made at and as of the
Closing Time. At the Closing Time, you shall have received a certificate of
the President or an Executive Vice President and the Chief Financial Officer
of the Company, dated as of the Closing Time, to such effect.

        (e) You shall have received a letter or letters from the Accountants
at the date hereof in form and substance reasonably satisfactory to the
Underwriters, and a letter or letters to be delivered at the Closing Time
reaffirming the statements made in each such letter or letters, except that
the inquiries and procedures specified therein shall have been carried out to
a specified date not more than five days prior to the Closing Time.

        (f) Subsequent to the execution and delivery of this Agreement and
prior to the Closing Time, there shall not have been any decrease in rating
accorded any of the Company's securities, including the Securities, by any
"nationally recognized statistical rating organization," as such term is
defined for purposes of Rule 436(g)(2) under the 1933 Act Regulations, and no
such organization shall have publicly announced that it has under surveillance
or review, without indicating an improvement, in its rating of the Securities
or any securities of the Company.

        (g) At the Closing Time, counsel for the Underwriters shall have been
furnished with all such documents, certificates and opinions as they may
reasonably request for the purpose of enabling them to pass upon the issuance
and sale of the Securities as herein contemplated and the matters referred to
in Section 5(c) and in order to evidence the accuracy and completeness of any
of the representations, warranties or statements of the Company, the
performance of any of the covenants of the Company, or the fulfillment of any
of the conditions herein contained; and all proceedings taken by the Company
at or prior to the Closing Time in connection with the authorization, issuance
and sale of the Securities as herein contemplated shall be reasonably
satisfactory in form and substance to you and to counsel for the Underwriters.

        (h) If any of the conditions specified in this Section 5 shall not
have been fulfilled when and as required by this Agreement to be fulfilled,
this Agreement may be terminated by you on notice to the Company at any time
at or prior to the Closing Time, and such termination shall be without
liability of any party to any other party, except as provided in Section 4
herein. Notwithstanding any such termination, the provisions of Sections 7, 8
and 9 shall remain in effect.

Section 6. Indemnification.

        (a) The Company agrees to indemnify and hold harmless each Underwriter
and each person, if any, who controls any Underwriter, as the case may be,
within the meaning of Section 15 of the 1933 Act, as follows:

              (i) against any and all loss, liability, claim, damage and
        expense whatsoever, as incurred, arising out of an untrue statement or
        alleged untrue statement of a material fact contained in the
        Registration Statement (or any amendment thereto), including all
        documents incorporated therein by reference, or the omission or
        alleged omission therefrom of a material fact required to be stated
        therein or necessary to make the statements therein not misleading or
        arising out of an untrue statement or alleged untrue statement of a
        material fact included in any preliminary prospectus supplement or the
        Prospectus (or any amendment or supplement thereto) or the omission or
        alleged omission therefrom of a material fact necessary in order to
        make the statements therein, in the light of the circumstances under
        which they were made, not misleading;

              (ii) against any and all loss, liability, claim, damage and
        expense whatsoever, as incurred, to the extent of the aggregate amount
        paid in settlement of any litigation or investigation or proceeding by
        any governmental agency or body, commenced or threatened, or of any
        claim whatsoever based upon any such untrue statement or omission, or
        any such alleged untrue statement or omission, if such settlement is
        effected with the written consent of the Company; and

              (iii) against any and all expense whatsoever, as incurred,
        including fees and disbursements of counsel chosen by you, reasonably
        incurred in investigating, preparing or defending against any
        litigation, or investigation or proceeding by any governmental agency
        or body, commenced or threatened, or any claim whatsoever based upon
        any such untrue statement or omission, or any such alleged untrue
        statement or omission, to the extent that any such expense is not paid
        under subparagraph (i) or (ii) above;

              (iv) provided, however, that this indemnity agreement does not
        apply to any loss, liability, claim, damage or expense to the extent
        arising out of an untrue statement or omission or alleged untrue
        statement or omission made in reliance upon and in conformity with
        written information furnished to the Company by any Underwriter
        through you expressly for use in the Registration Statement (or any
        amendment thereto) or any preliminary prospectus supplement or the
        Prospectus (or any amendment or supplement thereto); and provided,
        further, however, that the foregoing indemnification with respect to
        any preliminary prospectus supplement shall not inure to the benefit
        of any Underwriter (or any person controlling such Underwriter) from
        whom the person asserting any such losses, claims, damages or
        liabilities purchased any of the Securities if a copy of the
        Prospectus (as then amended or supplemented if the Company shall have
        furnished any amendments or supplements thereto) was not sent or given
        by or on behalf of such Underwriter to such person, if such is
        required by the 1933 Act, at or prior to the written confirmation of
        the sale of such Securities to such person and if the Prospectus (as
        so amended or supplemented) would have cured the defect giving rise to
        such loss, claim, damage or liability. The Company and the
        Underwriters acknowledge that the following statements set forth in
        the Prospectus Supplement constitute the only information furnished in
        writing by or on behalf of the Underwriters for inclusion in the
        Prospectus Supplement: (a) the statements set forth in last paragraph
        of the cover page regarding delivery of the Securities, (b) the
        statements set forth in the second sentence of the first paragraph on
        page i with respect to the Underwriters only, and (c) under the
        heading "Underwriting" (x) the sentences related to concessions and
        reallowances, (y) the paragraph related to stabilization, syndicate
        covering transactions and penalty bids, and (z) the fourth paragraph
        immediately following the table showing the underwriting discounts and
        commission.


        (b) Each Underwriter severally agrees to indemnify and hold harmless
the Company, its directors, each of its officers who signed the Registration
Statement, and each person, if any, who controls the Company within the
meaning of Section 15 of the 1933 Act, and of Section 20 of the 1934 Act, from
and against any and all loss, liability, claim, damage and expense described
in the indemnity agreement in Section 6(a), as incurred, but only with respect
to untrue statements or omissions, or alleged untrue statements or omissions,
made in the Registration Statement (or any amendment thereto) or any
preliminary prospectus supplement or the Prospectus (or any amendment or
supplement thereto) in reliance upon and in conformity with written
information furnished to the Company by or on behalf of such Underwriter
expressly for use in the Registration Statement (or any amendment thereto) or
such preliminary prospectus supplement or the Prospectus (or any amendment or
supplement thereto).

        (c) In case any proceeding (including any governmental investigation)
shall be instituted involving any person in respect of which indemnity may be
sought pursuant to any of the two preceding paragraphs, such person (the
"indemnified party") shall promptly notify the person against whom such
indemnity may be sought (the "indemnifying party") in writing and the
indemnifying party, upon request of the indemnified party, shall retain
counsel reasonably satisfactory to the indemnified party to represent the
indemnified party and any others the indemnifying party may designate in such
proceeding and shall pay the fees and disbursements of such counsel related to
such proceeding. In any such proceeding, any indemnified party shall have the
right to retain its own counsel, but the fees and expenses of such counsel
shall be at the expense of such indemnified party unless (i) the indemnifying
party and the indemnified party shall have mutually agreed to the retention of
such counsel or (ii) the named parties to any such proceeding (including any
impleaded parties) include both the indemnifying party and the indemnified
party and representation of both parties by the same counsel would be
inappropriate due to actual or potential differing interests between them. It
is understood that the indemnifying party shall not, in respect of the legal
expenses of any indemnified party in connection with any proceeding or related
proceedings in the same jurisdiction, be liable for the fees and expenses of
more than one separate firm (in addition to any local counsel) for all such
indemnified parties and that all such fees and expenses shall be reimbursed as
they are incurred. In the case of any such separate firm for the Underwriters
and such control persons of Underwriters, such firm shall be designated in
writing by the Underwriters. In the case of any such separate firm for the
Company, and such directors, officers and control persons of the Company, such
firm shall be designated in writing by the Company. The indemnifying party
shall not be liable for any settlement of any proceeding effected without its
written consent, but if settled with such consent or if there be a final
judgment for the plaintiff, the indemnifying party agrees to indemnify the
indemnified party from and against any loss or liability by reason of such
settlement or judgment. No indemnifying party shall, without the prior written
consent of the indemnified party, effect any settlement of any pending or
threatened proceeding in respect of which any indemnified party is or could
have been a party and indemnity could have been sought hereunder by such
indemnified party, unless such settlement includes an unconditional release of
such indemnified party from all liability on claims that are the subject
matter of such proceeding.

Section 7. Contribution. If the indemnification provided for in Sections 6(a)
and 6(b) is for any reason held to be unenforceable by the indemnified parties
although applicable in accordance with its terms, then each indemnifying party
under such paragraph (it being understood that an indemnifying party is one
who would have had an obligation to provide indemnification pursuant to
Section 6 had such indemnification been enforceable), in lieu of indemnifying
such indemnified party thereunder, shall contribute to the amount paid or
payable by such indemnified party as a result of such losses, claims, damages
or liabilities (i) in such proportion as is appropriate to reflect (A) the
relative benefits received by the Underwriters, and (B) that the Company is
responsible for the balance or (ii) if the allocation provided by clause (i)
above is not permitted by applicable law, in such proportion as is appropriate
to reflect not only the allocation referred to in clause (i)above but also the
relative fault of the indemnifying party or parties on the one hand and of the
indemnified party or parties on the other hand in connection with the
statements or omissions that resulted in such losses, claims, damages or
liabilities, as well as any other relevant equitable considerations. The
relative benefits received by the Company on the one hand and the Underwriters
on the other hand in connection with the offering of the Securities shall be
deemed to be in the same respective proportions as the net proceeds from the
offering of the Securities (before deducting expenses) received by the Company
and the total underwriting discounts and commissions received by the
Underwriters, in each case as set forth in the table on the cover of the
Prospectus Supplement, bear to the aggregate public offering price of the
Securities. The relative fault of the Company on the one hand and of the
Underwriters on the other hand shall be determined by reference to, among
other things, whether the untrue or alleged untrue statement of a material
fact or the omission or alleged omission to state a material fact relates to
information supplied by the Company or by the Underwriters and the parties'
relative intent, knowledge, access to information and opportunity to correct
or prevent such statement or omission. The Underwriters' respective
obligations to contribute pursuant to this Section 7 are several in proportion
to the respective number of Securities they have purchased hereunder, and not
joint.

        The Company and the Underwriters agree that it would not be just or
equitable if contribution pursuant to this Section 7 were determined by pro
rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation that does not take account of
the equitable considerations referred to in the immediately preceding
paragraph. The amount paid or payable by an indemnified party as a result of
the losses, claims, damages and liabilities referred to in the immediately
preceding paragraph shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses reasonably incurred by such
indemnified party in connection with investigating or defending any such
action or claim. Notwithstanding the provisions of this Section 7, no
Underwriter shall be required to contribute any amount in excess of the amount
by which the total price at which the Securities underwritten by it and
distributed to the public were offered to the public exceeds the amount of any
damages that such Underwriter has otherwise been required to pay by reason of
such untrue or alleged untrue statement or omission or alleged omission. No
person guilty of fraudulent misrepresentation (within the meaning of Section
11(f) of the 1933 Act) shall be entitled to contribution from any person who
was not guilty of such fraudulent misrepresentation. The remedies provided for
in this Section 7 are not exclusive and shall not limit any rights or remedies
which may otherwise be available to any indemnified party at law or in equity.
For purposes of this Section 7, each director and officer of each Underwriter,
and each person, if any, who controls each Underwriter within the meaning of
Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same
rights to contributions as each Underwriter, and each director and officer of
the Company who signed the Registration Statement, and each person, if any,
who controls the Company within the meaning of Section 15 of the 1933 Act or
Section 20 of the 1934 Act shall have the same rights to contribution at the
Company.

Section 8. Representations, Warranties and Agreements to Survive Delivery. The
representations, warranties, indemnities, agreements and other statements of
the Company or its officers set forth in or made pursuant to this Agreement
will remain operative and in full force and effect regardless of any
investigation made by or on behalf of the Company, any Underwriter or any
person who controls the Company or any Underwriter within the meaning of
Section 15 of the 1933 Act and will survive delivery of and payment for the
Securities.

Section 9. Termination of Agreement

        (a) You may terminate this Agreement, by notice to the Company, at any
time at or prior to the Closing Time (i) if there has been, since the
respective dates as of which information is given in the Registration
Statement, any material adverse change in the financial condition, earnings,
business affairs or business prospects of the Company and its Significant
Subsidiaries, considered as one enterprise, whether or not arising in the
ordinary course of business, or (ii) if there has occurred any material
adverse change in the financial markets in the United States or any outbreak
of hostilities or escalation thereof or other calamity or crisis the effect of
which on the financial markets of the United States is such as to make it, in
your judgment, impracticable to market the Securities or enforce contracts for
the sale of the Securities or (iii) if trading in any securities of the
Company has been suspended by the Commission, the New York Stock Exchange or
any other exchange or quotation system on which securities of the Company are
listed, or if trading generally on either the American Stock Exchange or the
New York Stock Exchange or in the over-the-counter market has been suspended,
or minimum or maximum prices for trading have been fixed, or maximum ranges
for prices for securities have been required, by such exchange or by order of
the Commission or any other governmental authority, or (iv) if a banking
moratorium has been declared by either federal, New Jersey or New York
authorities.

        (b) If this Agreement is terminated pursuant to this Section, such
termination shall be without liability of any party to any other party, except
to the extent provided in Section 4 herein. Notwithstanding any such
termination, the provisions of Sections 6, 7 and 8 shall remain in effect.

Section 10. Default by One or More of the Underwriters. If one or more of the
Underwriters shall fail at the Closing Time to purchase the Securities that it
or they are obligated to purchase (the "Defaulted Securities"), you shall have
the right, within 24 hours thereafter, to make arrangements for one or more of
the non-defaulting Underwriters, or any other underwriters, to purchase all,
but not less than all, of the Defaulted Securities in such amounts as may be
agreed upon and upon the terms herein set forth; if, however, you have not
completed such arrangements within such 24-hour period, then:

        (a) if the aggregate principal amount of Defaulted Securities does not
exceed 10% of the aggregate principal amount of the Securities to be purchased
pursuant to this Agreement, the non-defaulting Underwriters shall be obligated
to purchase the full amount thereof in the proportions that their respective
underwriting obligation proportions bear to the underwriting obligation
proportions (as defined below) of all non-defaulting Underwriters, or

        (b) if the aggregate principal amount of Defaulted Securities exceeds
10% of the aggregate principal amount of the Securities to be purchased
pursuant to this Agreement, this Agreement shall terminate without liability
on the part of any non-defaulting Underwriter.

        No action taken pursuant to this Section 10 shall relieve any
defaulting Underwriter from liability in respect of its default.

        In the event of any such default that does not result in a termination
of this Agreement, either you or the Company shall have the right to postpone
the Closing Time or the Delivery Date, as applicable for a period not
exceeding seven days in order to effect any required changes in the
Registration Statement or Prospectus or in any other documents or
arrangements. As used herein, the term "Underwriter" includes any person
substituted for an Underwriter under this Section 10.

Section 11. Notices. All notices and other communications hereunder shall be
in writing and shall be deemed to have been duly given if delivered, mailed or
transmitted by any standard form of telecommunication. Notices to the
Underwriters shall be directed as set forth in Schedule I. Notices to the
Company shall be directed to it at 9 West 57th Street, New York, NY 10019,
attention of Eric J. Bock, Executive Vice President, Law and Corporate
Secretary.

Section 12. Parties. This Agreement is made solely for the benefit of the
several Underwriters, the Company and, to the extent expressed, any person who
controls the Company or any of the Underwriters within the meaning of Section
15 of the 1933 Act, and the directors of the Company, its officers who have
signed the Registration Statement, and their respective executors,
administrators, successors and assigns and, subject to the provisions of
Section 11, no other person shall acquire or have any right under or by virtue
of this Agreement. The term "successors and assigns" shall not include any
purchaser, as such purchaser, from any Underwriter of the Securities. If there
are two or more Underwriters, all of their obligations hereunder are several
and not joint.

Section 13. Governing Law and Time. This Agreement shall be governed by the
laws of the State of New York. Specified times of the day refer to New York
City time.

Section 14. Counterparts. This Agreement may be executed in one or more
counterparts and when a counterpart has been executed by each party, all such
counterparts taken together shall constitute one and the same agreement.

Section 15. Headings. All headings of the sections and subparts thereof of
this Agreement are for convenience of reference only and shall not be deemed a
part of this Agreement.


        If the foregoing is in accordance with your understanding of our
agreement, please sign and return to us a counterpart hereof, whereupon this
instrument will become a binding agreement between the Company and each
Underwriter in accordance with its terms.

                               Very truly yours,

                               CENDANT CORPORATION

                               By: /s/ Eric J. Bock
                                   _________________________
                                   Name:  Eric J. Bock
                                   Title: Executive Vice
                                          President, Law and
                                          Corporate Secretary

Confirmed and Accepted, as of the date first above written:

J.P. MORGAN SECURITIES INC.

      By: /s/ Therese Esperdy
         _____________________
           Name:  Therese Esperdy
           Title: Managing Director

SALOMON SMITH BARNEY INC.

      By:  /s/ Scott R. White
           _____________________
           Name:  Scott R. White
           Title: Director

For themselves and the other Underwriters
named in Schedule I hereto




                            SCHEDULE I
                          to Underwriting
                          Agreement dated
                          January 8, 2003

                        CENDANT CORPORATION


Underwriter                  Principal amount of    Principal amount of
                             6.250% Senior Notes    7.375% Senior Notes
                             purchased              purchased

J.P. Morgan Securities Inc. $280,000,000           $420,000,000
Salomon Smith Barney Inc.    280,000,000            420,000,000
Banc of America               34,286,000             51,429,000
Securities LLC
Banc One Capital              34,286,000             51,429,000
Markets, Inc.
Barclays Capital Inc.         34,286,000             51,429,000
Credit Lyonnais               34,286,000             51,429,000
Securities (USA) Inc.
Scotia Capital (USA)          34,286,000             51,428,000
Inc.
The Royal Bank of             34,285,000             51,428,000
Scotland plc
Wachovia Securities,          34,285,000             51,428,000
Inc.
Total                       $800,000,000         $1,200,000,000




                            SCHEDULE II
                          to Underwriting
                             Agreement
                       dated January 8, 2003

                        CENDANT CORPORATION


                   6.250% Senior Notes due 2008

Principal amount to be issued:       $800,000,000

Interest rate:                       6.250% per annum, payable semiannually

Interest accrues from:               January 13, 2003

Date of maturity:                    January 15, 2008

Redemption provisions:               Make-whole of T + 45 bps

Sinking fund requirements:           None

Initial public offering price:       99.484% of the principal amount plus
                                     accrued interest from the date of
                                     issuance of the Securities.

Purchase price:                      98.884% of the principal amount plus
                                     accrued interest from the date of
                                     issuance of the Securities to the date of
                                     delivery (payable in same day funds)

Closing date, time and location:     January 13, 2003, 9:00 a.m., New York
                                     City time, Shearman & Sterling, 599
                                     Lexington Avenue, New York NY 10022


                   7.375% Senior Notes due 2013

Principal amount to be issued:       $1,200,000,000

Interest rate:                       7.375% per annum, payable semiannually

Interest accrues from:               January 13, 2003

Date of maturity:                    January 15, 2013

Redemption provisions:               Make-whole of T + 50 bps

Sinking fund requirements:           None

Initial public offering price:       99.096% of the principal amount plus
                                     accrued interest from the date of
                                     issuance of the Securities.

Purchase price:                      98.446% of the principal amount plus
                                     accrued interest from the date of
                                     issuance of the Securities to the date of
                                     delivery (payable in same day funds).

Closing date, time and location:     January 13, 2003, 9:00 a.m., New York
                                     City time, Shearman & Sterling, 599
                                     Lexington Avenue, New York NY 10022




                                                          Exhibit A

 FORM OF OPINION OF ERIC BOCK, SENIOR EXECUTIVE PRESIDENT, LAW AND
                CORPORATE SECRETARY OF THE COMPANY

Based upon and subject to the limitations, qualifications,
exceptions and assumptions set forth above, I am of the opinion
that:

                  (i) The Company has been incorporated and is validly
         existing as a corporation under the laws of the State of Delaware.

                  (ii) The Company has corporate power and authority (i) to
         own, lease and operate its properties and to conduct its business as
         described in the Registration Statement and the Prospectus and (ii)
         to enter into this Agreement and the Indenture and to perform its
         obligations under, or as contemplated under, each thereof.

                  (iii) The Company is qualified as a foreign corporation to
         transact business and is in good standing in each jurisdiction in
         which such qualification is required, except where the failure to so
         qualify or be in good standing would not result in a Material Adverse
         Effect.

                  (iv) The Company has authorized capital stock as set forth
         in the Prospectus (except for subsequent issuances, if any, pursuant
         to incentive compensation plan, employee benefit plan or dividend
         reinvestment and stock purchase plan transactions), and all of the
         issued and outstanding shares of common stock of the Company have
         been duly and validly authorized and issued and are fully paid and
         non-assessable; no holder thereof is or will be subject to personal
         liability by reason of being such a holder.

                  (v) Each Significant Subsidiary (as such term is defined in
         clauses (1) and (2) of Rule 1-02(w) of Regulation S-X promulgated
         under the 1933 Act) is duly organized and is validly existing and in
         good standing under the laws of the jurisdiction of its incorporation
         with corporate power and corporate authority under such laws to own,
         lease and operate its properties and conduct its business. Each
         Significant Subsidiary is duly qualified to transact business as a
         foreign corporation and is in good standing in each other
         jurisdiction in which it owns or leases property of a nature, or
         transacts business of a type, that would make such qualification
         necessary, except to the extent that the failure to so qualify or be
         in good standing would not have a Material Adverse Effect. Except as
         otherwise stated in the Prospectus, all of the outstanding shares of
         capital stock of each Significant Subsidiary have been duly
         authorized and validly issued and are fully paid and non-assessable
         and are owned by the Company, directly or through one or more
         Significant Subsidiaries, free and clear of any lien, except for such
         liens as are not, individually or in the aggregate, material to the
         Company and its Significant Subsidiaries, considered as one
         enterprise.

                  (vi) Each of the documents incorporated by reference in the
         Registration Statement and the Prospectus at the time they were filed
         or last amended (other than the financial statements and the notes
         thereto, the financial schedules, and any other financial data
         included or incorporated by reference therein, as to which I need
         express no belief), complied as to form in all material respects with
         the requirements of the 1934 Act and the 1934 Act Rules and
         Regulations, as applicable.

                  (vii) The Securities have been authorized for issuance and
         sale to the Underwriters pursuant to this Agreement and, when issued
         and delivered by the Company pursuant to this Agreement, will be
         validly issued and fully paid and non-assessable.

                  (viii) This Agreement has been duly authorized, executed and
         delivered by the Company.

                  (ix) The offer of the Securities as contemplated herein and
         in the Registration Statement and the Prospectus, the execution,
         delivery and performance of this Agreement, the Indenture and the
         Securities, and the consummation of the transactions contemplated
         herein, therein and in the Registration Statement and Prospectus
         (including the issuance and sale of the Securities and the use of
         proceeds from the sale of the Securities as described in the
         Registration Statement and Prospectus under the caption "Use of
         Proceeds") and compliance by the Company with its obligations
         hereunder and thereunder, have been authorized by all necessary
         corporate action and do not and will not, whether with or without the
         giving of notice or passage of time or both, conflict with or
         constitute a breach of any of the terms or provisions of, or
         constitute a default or Repayment Event under, or result in the
         creation or imposition of any lien, charge or encumbrance upon any
         property or assets of the Company or any Significant Subsidiary
         pursuant to, the Agreements and Instruments (except for such
         conflicts, breaches or defaults or liens, charges or encumbrances
         that would not result in a Material Adverse Effect), nor will such
         action result in any violation of any applicable law, statute, rule,
         regulation, judgment, order, writ or decree of any government,
         government instrumentality or court, domestic or foreign, having
         jurisdiction over the Company or any Significant Subsidiary or any of
         their assets, properties, or operations (except for such violations
         that would not result in a Material Adverse Effect), nor will such
         action result in any violation of the provisions of the charter or
         by-laws of the Company or any Significant Subsidiary.

                  (x) There are no statutes required to be described in or
         incorporated by reference in the Registration Statement and the
         Prospectus that are not described or incorporated by reference; and
         there are no legal or governmental proceedings pending or, to my
         knowledge, threatened that are required to be disclosed or
         incorporated by reference in the Registration Statement and
         Prospectus, other than those disclosed or incorporated by reference
         therein.

                  (xi) There are no contracts, indentures, mortgages,
         agreements, notes, leases or other instruments required to be
         described or referred to or incorporated by reference in the
         Registration Statement and the Prospectus other than those described
         or referred to or incorporated by reference therein; and the
         descriptions thereof or references thereto are true and correct in
         all material respects.

Moreover, nothing has come to my attention that causes me to believe that the
Registration Statement, on the original effective date of the Registration
Statement, on the date of the filing of any annual report on Form 10-K or Form
10-K/A after the filing of the Registration Statement, or on the date of this
Agreement, contained or contains an untrue statement of a material fact or
omitted or omits to state material fact necessary, in light of the
circumstances under which they were made, to make the statements therein not
misleading, or that the Prospectus, or any amendment or supplement thereto, at
the time the Prospectus Supplement was issued or at the date hereof, contained
or contains an untrue statement of a material fact or omitted or omits to
state a material fact necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading, except
that I express no opinion or belief with respect to the financial statements,
schedules and other financial or statistical data included or incorporated by
reference therein or excluded therefrom.




                                                          Exhibit B

    FORM OF OPINION OF SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP

Based upon and subject to the limitations, qualifications,
exceptions and assumptions set forth above, we are of the opinion
that:

                  (i) The Indenture has been duly authorized, executed and
         delivered by the Company and constitutes a valid and binding
         agreement of the Company, enforceable against the Company in
         accordance with its terms, except to the extent enforcement thereof
         might be limited by (i) applicable bankruptcy, insolvency, fraudulent
         conveyance, reorganization, moratorium or other similar laws now or
         hereafter in effect relating to creditors' rights generally and (ii)
         general principles of equity (regardless of whether enforceability is
         sought in equity or at law);

                  (ii) This Agreement has been duly authorized, executed and
         delivered by the Company;

                  (iii) The Securities have been duly authorized by the
         Company and, when duly authenticated in accordance with the terms of
         the Indenture and delivered to and paid for by the Underwriters in
         accordance with the terms of this Agreement, will be valid and
         binding obligations of the Company, enforceable against the Company
         in accordance with their terms and will be entitled to the benefits
         of the Indenture, except to the extent enforcement thereof might be
         limited by (i) applicable bankruptcy, insolvency, fraudulent
         conveyance, reorganization, moratorium or other similar laws now or
         hereafter in effect relating to creditors' rights generally and (ii)
         general principles of equity (regardless of whether enforceability is
         considered sought in equity or at law);

                  (iv) The statements included in the Registration Statement
         and the Prospectus under the captions "Description of Notes," insofar
         as such statements purport to summarize certain provisions of
         documents referred to therein, fairly summarize such provisions in
         all material respects;

                  (v) The statements set forth in the Base Prospectus under
         the captions "Description of the Debt Securities" and "General
         Description of Capital Stock," insofar as such statements purport to
         summarize certain provisions of the documents referred to therein,
         fairly summarize such provisions in all material respects.

                  (vi) The Registration Statement, as of the date of filing of
         the Company's Annual Report on Form 10-K/A for the year ended
         December 31, 2001, and the Prospectus, as of the date of the
         Prospectus Supplement, appeared on their face to be appropriately
         responsive in all material respects to the requirements of the 1933
         Act and the Rules and Regulations, except that in each case we do not
         express any opinion as to the financial statements and schedules and
         other financial data included or incorporated by reference therein or
         excluded therefrom, or the exhibits to the Registration Statement,
         including the Statement of Eligibility on Form T-1, and, except to
         the extent expressly stated in paragraphs (iv) and (v) above, we do
         not assume any responsibility for the accuracy, completeness or
         fairness of the statements contained in the Registration Statement or
         the Prospectus.

                  (vii) The execution, delivery and performance of this
         Agreement, the Securities or the Indenture does not require any
         authorization, approval, consent, order, registration or
         qualification of any court or governmental authority or agency to be
         made or obtained by the Company.

                  (viii) The Company is not and, solely after giving effect to
         the offering and the sale of the Securities and the application of
         the proceeds thereof described in the Registration Statement and
         Prospectus, will not be subject to registration and regulation as an
         "investment company" as such term is defined in the Investment
         Company Act of 1940, as amended.

In addition, in connection with the preparation of the Registration Statement
and the Prospectus, we have participated in conferences with officers and
representatives of the Company, in-house counsel for the Company,
representatives of the independent accountants of the Company, and you and
your counsel at which conferences the contents of the Registration Statement
and the Prospectus and related matters were discussed. We did not participate
in the preparation of the documents filed by the Company pursuant to the 1934
Act and incorporated by reference into the Prospectus as of the Closing Time
but have, however, reviewed such documents and discussed the business and
affairs of the Company with officers and other representatives of the Company.
Although we are not passing upon, and do not assume any responsibility for,
the accuracy, completeness or fairness of the statements contained in the
Prospectus and we have made no independent check or verification thereof,
other than to the extent specified in paragraph (iv) above, on the basis of
the foregoing, no facts have come to our attention that have led us to believe
that the Registration Statement, as of the date of the Company's Annual Report
on Form 10-K/A for the year ended December 31, 2001, contained an untrue
statement of a material fact or omitted to state any material fact required to
be stated therein or necessary to make the statements therein not misleading
or that the Prospectus, as of the date of the Prospectus Supplement and as of
the date hereof, contained or contains an untrue statement of a material fact
or omitted or omits to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were
made not misleading, except that we express no opinion or belief with respect
to the financial statements, schedules and other financial data included or
incorporated by reference therein or excluded therefrom or the exhibits to the
Registration Statement.

                               Very truly yours,